Sort
10,766 grants matching “checkpoint inhibitor”
Metabolic Influences on Complex Tumor Neighborhoods
$925,000M. Celeste Simon · University Of Pennsylvania · R35 · FY2023 · CA
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$924,838Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2018 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$924,682Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$924,071Ronald Levy · Stanford University · R35 · FY2016 · CA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$923,400Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast Cancer
$923,254Emek Demir · Oregon Health & Science University · U2C · FY2023 · CA
Data Processing, Analysis and Modeling Unit
$923,254Jeremy Goecks · Oregon Health & Science University · U2C · FY2023 · CA
Systems genetics analysis of tumor evolution in the mouse
$922,470Allan Balmain · University Of California, San Francisco · R35 · FY2019 · CA
Metabolic Influences on Complex Tumor Neighborhoods
$921,582M. Celeste Simon · University Of Pennsylvania · R35 · FY2024 · CA
A single-cell device to capture and analyze rare T-cells from solid tumors.
$920,072Timothy S McConnell · Isoplexis, Inc. · R44 · FY2018 · CA
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$919,541Darell D Bigner · Duke University · R35 · FY2021 · CA
Specialized Program Of Research Excellence (SPORE) in Leukemia.
$918,606Daniel C Link · Washington University · P50 · FY2023 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$917,279Antoni Ribas · University Of California Los Angeles · R35 · FY2023 · CA
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
$916,550Dennis E. Discher · University Of Pennsylvania · U01 · FY2021 · CA
Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation
$915,790Robert J Coffey · Vanderbilt University Medical Center · R35 · FY2025 · CA
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$912,796Darell D Bigner · Duke University · R35 · FY2018 · CA
Regulation of stem cell development during tissue remodeling
$911,209Yun-Bo Shi · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Optimizing AAV delivery of bNAbs for HIV prevention
$909,998Matthew Ryan Gardner · Emory University · R01 · FY2023 · AI
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$909,837Ronald Levy · Stanford University · R35 · FY2017 · CA
Human Monoclonal Antibodies Against Cancer
$909,717Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$909,357Luke O. Russell · Vyriad, Inc. · R44 · FY2019 · CA
Optimizing AAV delivery of bNAbs for HIV prevention
$908,948Matthew Ryan Gardner · Emory University · R01 · FY2024 · AI
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
$908,910Michael Demetriou · Glytr Therapeutics, Inc. · R42 · FY2024 · CA
Targeting Gq pathway in uveal melanoma
$908,647Xu Chen · University Of California, San Francisco · R01 · FY2025 · CA